HealthQuill Health
Novo Nordisk, one of the world’s most valuable companies, will acquire Germany-based Cardior Pharmaceuticals, a firm that specialises in heart diseases, for up to 1.03 billion euros ($1.1 billion).
Drugs Health Pharma

Novo to buy Cardior for $1.1b to expand cardiovascular segment

HQ Team March 25, 2024: Novo Nordisk, one of the world’s most valuable companies, will acquire Germany-based Cardior Pharmaceuticals, a firm that specialises.

Read More
Food crisis
Climate Health Medical

Urban dwellers losing their ability to digest plant cellulose

HQ Team March 22, 2024: A recent study titled “Cryptic diversity of cellulose-degrading gut bacteria in industrialized humans” says that urban dwellers are.

Read More
Richard Slayman, 62, of Weymouth, Massachusetts, became the first human to receive a kidney from a genetically modified pig, according to a statement from Massachusetts General Hospital.
Drugs Health Pharma

First genetically edited pig kidney gets transplanted into a human

HQ Team March 21, 2024: Richard Slayman, 62, of Weymouth, Massachusetts, became the first human to receive a kidney from a genetically modified.

Read More
An abnormal protein called phosphorylated α-synuclein present in the nerve fibres in the skin — the pathological hallmark of Parkinson’s disease — can be detected with high accuracy by a simple biopsy test, researchers say.
Drugs Health Pharma

Simple skin biopsy test can detect Parkinson’s disease: Harvard study

HQ Team March 21, 2024: An abnormal protein called phosphorylated α-synuclein present in the nerve fibres in the skin — the pathological hallmark.

Read More
Noland Arbaugh, 29, the first human to receive Neuralink’s brain implant, was able to play online chess and a video game using the device, according to a video posted by billionaire Elon Musk’s X platform.
Drugs Health Medical

Neuralink’s first brain implant human plays chess, video game online

HQ Team March 21, 2024: Noland Arbaugh, 29, the first human to receive Neuralink’s brain implant, was able to play online chess and.

Read More
A panel consisting of Nobel laureates, former presidents and prime ministers has urged global negotiators of WHO member states to redouble their efforts to reach a consensus on the Pandemic Accord.
Drugs Health Pharma

Negotiators must close Pandemic Accord talks fast: Global panel

HQ Team March 21, 2024: A panel consisting of Nobel laureates, former presidents and prime ministers have urged global negotiators of WHO member.

Read More
Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival for its investigational therapy to treat liver cancer.
Drugs Health Pharma

Bristol Myers says liver cancer therapy trial improves overall survival rate

HQ Team March 20, 2024: Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival.

Read More
The Covid-19 virus can damage the heart, even without directly affecting the heart tissue, according to a study by the National Institutes of Health (NIH).
Drugs Health Pharma

Severe Covid-19 infection can cause heart damage: NIH study says

HQ Team March 20, 2024: The Covid-19 virus can damage the heart, even without directly affecting the heart tissue, according to a study.

Read More
The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in South Africa, which has one of the highest burdens in the world.
Drugs Health Pharma

First late-stage trial vaccine doses begin in South Africa for tuberculosis

 HQ Team March 20, 2024: The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in.

Read More
Anglo-Swedish drugmaker, AstraZeneca will acquire clinical-stage Fusion Pharmaceuticals for $2 billion in cash to get access to the latter’s radioconjugates to treat cancer.
Drugs Health Pharma

AstraZeneca to acquire Fusion Pharmaceuticals for $2 billion in cash

HQ Team March 20, 2024: Anglo-Swedish drugmaker, AstraZeneca will acquire clinical-stage Fusion Pharmaceuticals for $2 billion in cash to get access to the.

Read More